Similar articles for PMID: 21778314

Year	Number of Results
2000	1
2002	3
2003	1
2004	2
2005	3
2006	4
2007	5
2008	15
2009	13
2010	6
2011	5
2012	3
2014	3
2015	2
2021	1
2024	0

1

Cell-free DNA in the circulation as a potential cancer biomarker.

Kohler C, Barekati Z, Radpour R, Zhong XY. Kohler C, et al. Anticancer Res. 2011 Aug;31(8):2623-8. Anticancer Res. 2011. PMID: 21778314 Review.

2

Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?

van der Vaart M, Pretorius PJ. van der Vaart M, et al. Clin Biochem. 2010 Jan;43(1-2):26-36. doi: 10.1016/j.clinbiochem.2009.08.027. Epub 2009 Sep 9. Clin Biochem. 2010. PMID: 19747472 Review.

3

Cell-free circulating mitochondrial DNA in the serum: a potential non-invasive biomarker for Ewing's sarcoma.

Yu M, Wan YF, Zou QH. Yu M, et al. Arch Med Res. 2012 Jul;43(5):389-94. doi: 10.1016/j.arcmed.2012.06.007. Epub 2012 Jun 21. Arch Med Res. 2012. PMID: 22728238

4

Circulating cell-free mitochondrial DNA as a novel cancer biomarker: opportunities and challenges.

Yu M. Yu M. Mitochondrial DNA. 2012 Oct;23(5):329-32. doi: 10.3109/19401736.2012.696625. Epub 2012 Jul 9. Mitochondrial DNA. 2012. PMID: 22775429 Review.

5

Circulating DNA and lung cancer.

Xue X, Zhu YM, Woll PJ. Xue X, et al. Ann N Y Acad Sci. 2006 Sep;1075:154-64. doi: 10.1196/annals.1368.021. Ann N Y Acad Sci. 2006. PMID: 17108206 Review.

6

Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia.

Müller I, Urban K, Pantel K, Schwarzenbach H. Müller I, et al. Ann N Y Acad Sci. 2006 Sep;1075:222-9. doi: 10.1196/annals.1368.030. Ann N Y Acad Sci. 2006. PMID: 17108215

7

Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.

Hsu HS, Chen TP, Wen CK, Hung CH, Chen CY, Chen JT, Wang YC. Hsu HS, et al. J Pathol. 2007 Dec;213(4):412-9. doi: 10.1002/path.2246. J Pathol. 2007. PMID: 17973238

8

Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.

Wang Y, Yu Z, Wang T, Zhang J, Hong L, Chen L. Wang Y, et al. Lung Cancer. 2007 May;56(2):289-94. doi: 10.1016/j.lungcan.2006.12.007. Epub 2007 Jan 30. Lung Cancer. 2007. PMID: 17267069

9

Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.

Schwarzenbach H, Müller V, Stahmann N, Pantel K. Schwarzenbach H, et al. Ann N Y Acad Sci. 2004 Jun;1022:25-32. doi: 10.1196/annals.1318.005. Ann N Y Acad Sci. 2004. PMID: 15251935

10

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.

Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, De Franco S, Brini M, Sgarbi G, Lodi R. Paci M, et al. Lung Cancer. 2009 Apr;64(1):92-7. doi: 10.1016/j.lungcan.2008.07.012. Epub 2008 Sep 19. Lung Cancer. 2009. PMID: 18804892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year